{"transactions":[{"id":677513,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2026-08-24T20:57:08.000Z","date":"2026-08-20","kind":"grant","planned":false,"acquired":true,"shares":57600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 20, 2027, which is the first anniversary of the grant date."}],"balance_after":148007,"source":{"system":"sec-edgar","filing":"0001628280-26-058669","document":"wk-form4_1787605026.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828026058669/wk-form4_1787605026.xml","form_type":"4"}},{"id":677512,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2026-08-24T19:12:57.000Z","date":"2026-08-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":1529,"price":7.71,"value":11788.59,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":90407,"source":{"system":"sec-edgar","filing":"0001628280-26-058586","document":"wk-form4_1787598774.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828026058586/wk-form4_1787598774.xml","form_type":"4"}},{"id":905347,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Restricted Stock Units","published_at":"2026-02-13T16:49:55.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date"}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001628280-26-007972","document":"wk-form4_1771001391.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828026007972/wk-form4_1771001391.xml","form_type":"4"}},{"id":905346,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2026-02-13T16:49:55.000Z","date":"2026-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1386,"price":9.23,"value":12792.78,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":91936,"source":{"system":"sec-edgar","filing":"0001628280-26-007972","document":"wk-form4_1771001391.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828026007972/wk-form4_1771001391.xml","form_type":"4"}},{"id":905345,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2026-02-13T16:49:55.000Z","date":"2026-02-11","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":93322,"source":{"system":"sec-edgar","filing":"0001628280-26-007972","document":"wk-form4_1771001391.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828026007972/wk-form4_1771001391.xml","form_type":"4"}},{"id":959734,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-12-23T21:53:55.000Z","date":"2025-12-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":4051,"price":12.74,"value":51609.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":89322,"source":{"system":"sec-edgar","filing":"0001628280-25-058763","document":"wk-form4_1766526832.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025058763/wk-form4_1766526832.xml","form_type":"4"}},{"id":961090,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Restricted Stock Units","published_at":"2025-12-22T15:09:28.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":false,"shares":3928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date."}],"balance_after":3928,"derivative":{"exercise_date":"2024-12-19","expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":3928},"source":{"system":"sec-edgar","filing":"0001628280-25-058411","document":"wk-form4_1766416165.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025058411/wk-form4_1766416165.xml","form_type":"4"}},{"id":961089,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-12-22T15:09:28.000Z","date":"2025-12-19","kind":"tax_withholding","planned":false,"acquired":false,"shares":1153,"price":13.51,"value":15577.03,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":93373,"source":{"system":"sec-edgar","filing":"0001628280-25-058411","document":"wk-form4_1766416165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025058411/wk-form4_1766416165.xml","form_type":"4"}},{"id":961088,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-12-22T15:09:28.000Z","date":"2025-12-19","kind":"exercise","planned":false,"acquired":true,"shares":3928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":94526,"source":{"system":"sec-edgar","filing":"0001628280-25-058411","document":"wk-form4_1766416165.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025058411/wk-form4_1766416165.xml","form_type":"4"}},{"id":1022267,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Restricted Stock Units","published_at":"2025-10-07T22:46:15.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":false,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6649},"source":{"system":"sec-edgar","filing":"0001628280-25-044549","document":"wk-form4_1759877172.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025044549/wk-form4_1759877172.xml","form_type":"4"}},{"id":1022266,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-10-07T22:46:15.000Z","date":"2025-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1952,"price":18.75,"value":36600.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":90598,"source":{"system":"sec-edgar","filing":"0001628280-25-044549","document":"wk-form4_1759877172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025044549/wk-form4_1759877172.xml","form_type":"4"}},{"id":1022265,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-10-07T22:46:15.000Z","date":"2025-10-03","kind":"exercise","planned":false,"acquired":true,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":92550,"source":{"system":"sec-edgar","filing":"0001628280-25-044549","document":"wk-form4_1759877172.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025044549/wk-form4_1759877172.xml","form_type":"4"}},{"id":1056877,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Stock Option","published_at":"2025-08-25T20:29:19.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":35156,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning August 21, 2026, the first anniversary of the grant date."}],"balance_after":35156,"derivative":{"exercise_price":16.14,"exercise_date":"2026-08-21","expiration_date":"2030-08-21","underlying":"Common Stock","underlying_shares":35156},"source":{"system":"sec-edgar","filing":"0001628280-25-041117","document":"wk-form4_1756153755.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025041117/wk-form4_1756153755.xml","form_type":"4"}},{"id":1056876,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal & Admin Officer"}}],"security":"Common Stock","published_at":"2025-08-25T20:29:19.000Z","date":"2025-08-21","kind":"grant","planned":false,"acquired":true,"shares":15625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on August 21, 2026, which is the first anniversary of the grant date."}],"balance_after":85901,"source":{"system":"sec-edgar","filing":"0001628280-25-041117","document":"wk-form4_1756153755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025041117/wk-form4_1756153755.xml","form_type":"4"}},{"id":1229302,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & CHRO"}}],"security":"Restricted Stock Units","published_at":"2025-03-04T14:16:52.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":false,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vested in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":771},"source":{"system":"sec-edgar","filing":"0001628280-25-009628","document":"wk-form4_1741097805.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025009628/wk-form4_1741097805.xml","form_type":"4"}},{"id":1229301,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & CHRO"}}],"security":"Common Stock","published_at":"2025-03-04T14:16:52.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":268,"price":5.18,"value":1388.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":70276,"source":{"system":"sec-edgar","filing":"0001628280-25-009628","document":"wk-form4_1741097805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025009628/wk-form4_1741097805.xml","form_type":"4"}},{"id":1229300,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & CHRO"}}],"security":"Common Stock","published_at":"2025-03-04T14:16:52.000Z","date":"2025-03-01","kind":"exercise","planned":false,"acquired":true,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."}],"balance_after":70544,"source":{"system":"sec-edgar","filing":"0001628280-25-009628","document":"wk-form4_1741097805.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025009628/wk-form4_1741097805.xml","form_type":"4"}},{"id":1256006,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer & CHRO"}}],"security":"Common Stock","published_at":"2025-02-20T18:38:51.000Z","date":"2025-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1479,"price":6.64,"value":9820.56,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":69773,"source":{"system":"sec-edgar","filing":"0001628280-25-006687","document":"wk-form4_1740076725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025006687/wk-form4_1740076725.xml","form_type":"4"}},{"id":1269745,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2025-02-13T20:58:00.000Z","date":"2025-02-11","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":12000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001628280-25-005384","document":"wk-form4_1739480272.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025005384/wk-form4_1739480272.xml","form_type":"4"}},{"id":1269744,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2025-02-13T20:58:00.000Z","date":"2025-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1386,"price":5.6,"value":7761.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":71252,"source":{"system":"sec-edgar","filing":"0001628280-25-005384","document":"wk-form4_1739480272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025005384/wk-form4_1739480272.xml","form_type":"4"}},{"id":1269743,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2025-02-13T20:58:00.000Z","date":"2025-02-11","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":72638,"source":{"system":"sec-edgar","filing":"0001628280-25-005384","document":"wk-form4_1739480272.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828025005384/wk-form4_1739480272.xml","form_type":"4"}},{"id":1321022,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Stock Option","published_at":"2024-12-27T19:08:47.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":77742,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests in three equal annual installments beginning December 23, 2025, the first anniversary of the grant date."}],"balance_after":77742,"derivative":{"exercise_price":4.83,"exercise_date":"2025-12-23","expiration_date":"2027-12-23","underlying":"Common Stock","underlying_shares":77742},"source":{"system":"sec-edgar","filing":"0001628280-24-052486","document":"wk-form4_1735326521.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024052486/wk-form4_1735326521.xml","form_type":"4"}},{"id":1321021,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-12-27T19:08:47.000Z","date":"2024-12-23","kind":"grant","planned":false,"acquired":true,"shares":41408,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in three equal annual installments beginning on December 23, 2025, which is the first anniversary of the date of grant."}],"balance_after":68638,"source":{"system":"sec-edgar","filing":"0001628280-24-052486","document":"wk-form4_1735326521.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024052486/wk-form4_1735326521.xml","form_type":"4"}},{"id":1324242,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2024-12-21T00:48:14.000Z","date":"2024-12-19","kind":"exercise","planned":false,"acquired":false,"shares":3927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning December 19, 2024, the first anniversary of the grant date."}],"balance_after":7856,"derivative":{"exercise_date":"2024-12-19","expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":3927},"source":{"system":"sec-edgar","filing":"0001628280-24-052287","document":"wk-form4_1734742087.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024052287/wk-form4_1734742087.xml","form_type":"4"}},{"id":1324241,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-12-21T00:48:14.000Z","date":"2024-12-20","kind":"tax_withholding","planned":false,"acquired":false,"shares":1153,"price":4.75,"value":5476.75,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":27230,"source":{"system":"sec-edgar","filing":"0001628280-24-052287","document":"wk-form4_1734742087.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024052287/wk-form4_1734742087.xml","form_type":"4"}},{"id":1324240,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-12-21T00:48:14.000Z","date":"2024-12-19","kind":"exercise","planned":false,"acquired":true,"shares":3927,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":28383,"source":{"system":"sec-edgar","filing":"0001628280-24-052287","document":"wk-form4_1734742087.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024052287/wk-form4_1734742087.xml","form_type":"4"}},{"id":1369156,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2024-11-12T14:37:56.000Z","date":"2024-11-08","kind":"exercise","planned":false,"acquired":false,"shares":1785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On November 8, 2021, the reporting person was granted 5,355 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On November 8, 2021, the reporting person was granted 5,355 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1785},"source":{"system":"sec-edgar","filing":"0001628280-24-046917","document":"wk-form4_1731422269.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024046917/wk-form4_1731422269.xml","form_type":"4"}},{"id":1369155,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-11-12T14:37:56.000Z","date":"2024-11-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":524,"price":6.27,"value":3285.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":24456,"source":{"system":"sec-edgar","filing":"0001628280-24-046917","document":"wk-form4_1731422269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024046917/wk-form4_1731422269.xml","form_type":"4"}},{"id":1369154,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-11-12T14:37:56.000Z","date":"2024-11-08","kind":"exercise","planned":false,"acquired":true,"shares":1785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":24980,"source":{"system":"sec-edgar","filing":"0001628280-24-046917","document":"wk-form4_1731422269.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024046917/wk-form4_1731422269.xml","form_type":"4"}},{"id":1390215,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2024-10-08T01:26:39.000Z","date":"2024-10-03","kind":"exercise","planned":false,"acquired":false,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":6649,"derivative":{"underlying":"Common Stock","underlying_shares":6649},"source":{"system":"sec-edgar","filing":"0001628280-24-042476","document":"wk-form4_1728350793.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024042476/wk-form4_1728350793.xml","form_type":"4"}},{"id":1390214,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-10-08T01:26:39.000Z","date":"2024-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1952,"price":7.83,"value":15284.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":23195,"source":{"system":"sec-edgar","filing":"0001628280-24-042476","document":"wk-form4_1728350793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024042476/wk-form4_1728350793.xml","form_type":"4"}},{"id":1390213,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-10-08T01:26:39.000Z","date":"2024-10-03","kind":"exercise","planned":false,"acquired":true,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":25147,"source":{"system":"sec-edgar","filing":"0001628280-24-042476","document":"wk-form4_1728350793.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024042476/wk-form4_1728350793.xml","form_type":"4"}},{"id":1536254,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-04-24T14:17:43.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":4267,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant of restricted stock units representing a contingent right to receive shares of OptimizeRx common stock. The restricted stock units will vest in full on February 15, 2025, which is the first anniversary of the date of grant."}],"balance_after":18498,"source":{"system":"sec-edgar","filing":"0001628280-24-017550","document":"wk-form4_1713968255.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024017550/wk-form4_1713968255.xml","form_type":"4"}},{"id":1591958,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2024-03-06T21:19:04.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":false,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":771,"derivative":{"underlying":"Common Stock","underlying_shares":771},"source":{"system":"sec-edgar","filing":"0001628280-24-009405","document":"wk-form4_1709759929.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024009405/wk-form4_1709759929.xml","form_type":"4"}},{"id":1591957,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-03-06T21:19:04.000Z","date":"2024-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":268,"price":15.95,"value":4274.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":14231,"source":{"system":"sec-edgar","filing":"0001628280-24-009405","document":"wk-form4_1709759929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024009405/wk-form4_1709759929.xml","form_type":"4"}},{"id":1591956,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-03-06T21:19:04.000Z","date":"2024-03-01","kind":"exercise","planned":false,"acquired":true,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":14499,"source":{"system":"sec-edgar","filing":"0001628280-24-009405","document":"wk-form4_1709759929.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024009405/wk-form4_1709759929.xml","form_type":"4"}},{"id":1629626,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2024-02-21T23:23:29.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":11783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 19, 2024, the first anniversary of the grant date."}],"balance_after":11783,"derivative":{"exercise_date":"2024-12-19","expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":11783},"source":{"system":"sec-edgar","filing":"0001628280-24-006019","document":"wk-form4_1708557790.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024006019/wk-form4_1708557790.xml","form_type":"4"}},{"id":1629625,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Stock Option","published_at":"2024-02-21T23:23:29.000Z","date":"2023-12-19","kind":"grant","planned":false,"acquired":true,"shares":11783,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options vest in three equal annual installments beginning October 19, 2024, the first anniversary of the grant date."}],"balance_after":11783,"derivative":{"exercise_price":12.73,"exercise_date":"2024-12-19","expiration_date":"2026-12-19","underlying":"Common Stock","underlying_shares":11783},"source":{"system":"sec-edgar","filing":"0001628280-24-006019","document":"wk-form4_1708557790.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024006019/wk-form4_1708557790.xml","form_type":"4"}},{"id":1646470,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2024-02-13T23:16:31.000Z","date":"2024-02-11","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":16000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001628280-24-004575","document":"wk-form4_1707866168.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024004575/wk-form4_1707866168.xml","form_type":"4"}},{"id":1646469,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-02-13T23:16:31.000Z","date":"2024-02-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":1386,"price":15.39,"value":21330.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":13728,"source":{"system":"sec-edgar","filing":"0001628280-24-004575","document":"wk-form4_1707866168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024004575/wk-form4_1707866168.xml","form_type":"4"}},{"id":1646468,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-02-13T23:16:31.000Z","date":"2024-02-11","kind":"exercise","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":15114,"source":{"system":"sec-edgar","filing":"0001628280-24-004575","document":"wk-form4_1707866168.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024004575/wk-form4_1707866168.xml","form_type":"4"}},{"id":1680843,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2024-01-11T22:06:09.000Z","date":"2024-01-09","kind":"sale","planned":true,"acquired":false,"shares":4000,"price":15.1877,"value":60750.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.01 to $15.41. The reporting person undertakes to provide to OptimizeRx Corporation, any security holder of OptimizeRx Corporation or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":11114,"source":{"system":"sec-edgar","filing":"0001628280-24-001190","document":"wk-form4_1705010757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828024001190/wk-form4_1705010757.xml","form_type":"4"}},{"id":1744157,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2023-11-13T19:32:54.000Z","date":"2023-11-08","kind":"exercise","planned":false,"acquired":false,"shares":1785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On November 8, 2021, the reporting person was granted 5,355 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On November 8, 2021, the reporting person was granted 5,355 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1785,"derivative":{"underlying":"Common Stock","underlying_shares":1785},"source":{"system":"sec-edgar","filing":"0001628280-23-038536","document":"wk-form4_1699903962.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023038536/wk-form4_1699903962.xml","form_type":"4"}},{"id":1744156,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2023-11-13T19:32:54.000Z","date":"2023-11-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":524,"price":9.21,"value":4826.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":15114,"source":{"system":"sec-edgar","filing":"0001628280-23-038536","document":"wk-form4_1699903962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023038536/wk-form4_1699903962.xml","form_type":"4"}},{"id":1744155,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2023-11-13T19:32:54.000Z","date":"2023-11-08","kind":"exercise","planned":false,"acquired":true,"shares":1785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":15638,"source":{"system":"sec-edgar","filing":"0001628280-23-038536","document":"wk-form4_1699903962.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023038536/wk-form4_1699903962.xml","form_type":"4"}},{"id":1763729,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2023-10-06T18:47:51.000Z","date":"2023-10-03","kind":"exercise","planned":false,"acquired":false,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":13298,"derivative":{"underlying":"Common Stock","underlying_shares":6649},"source":{"system":"sec-edgar","filing":"0001628280-23-034061","document":"wk-form4_1696618061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023034061/wk-form4_1696618061.xml","form_type":"4"}},{"id":1763728,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2023-10-06T18:47:51.000Z","date":"2023-10-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":1952,"price":7.06,"value":13781.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":13853,"source":{"system":"sec-edgar","filing":"0001628280-23-034061","document":"wk-form4_1696618061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023034061/wk-form4_1696618061.xml","form_type":"4"}},{"id":1763727,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2023-10-06T18:47:51.000Z","date":"2023-10-03","kind":"exercise","planned":false,"acquired":true,"shares":6649,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":15805,"source":{"system":"sec-edgar","filing":"0001628280-23-034061","document":"wk-form4_1696618061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023034061/wk-form4_1696618061.xml","form_type":"4"}},{"id":1974474,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2023-03-03T20:41:00.000Z","date":"2023-03-01","kind":"exercise","acquired":false,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":1542,"derivative":{"underlying":"Common Stock","underlying_shares":771},"source":{"system":"sec-edgar","filing":"0001628280-23-006262","document":"wf-form4_167787603939131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023006262/wf-form4_167787603939131.xml","form_type":"4"}},{"id":1974473,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2023-03-03T20:41:00.000Z","date":"2023-03-01","kind":"tax_withholding","acquired":false,"shares":268,"price":18.11,"value":4853.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":9156,"source":{"system":"sec-edgar","filing":"0001628280-23-006262","document":"wf-form4_167787603939131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023006262/wf-form4_167787603939131.xml","form_type":"4"}},{"id":1974472,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2023-03-03T20:41:00.000Z","date":"2023-03-01","kind":"exercise","acquired":true,"shares":771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":9424,"source":{"system":"sec-edgar","filing":"0001628280-23-006262","document":"wf-form4_167787603939131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023006262/wf-form4_167787603939131.xml","form_type":"4"}},{"id":2016820,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2023-02-14T16:32:14.000Z","date":"2023-02-11","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date"}],"balance_after":12000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001628280-23-003460","document":"wf-form4_167639231734061.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023003460/wf-form4_167639231734061.xml","form_type":"4"}},{"id":2016819,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2023-02-14T16:32:14.000Z","date":"2023-02-11","kind":"tax_withholding","acquired":false,"shares":1422,"price":17.34,"value":24657.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":8653,"source":{"system":"sec-edgar","filing":"0001628280-23-003460","document":"wf-form4_167639231734061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023003460/wf-form4_167639231734061.xml","form_type":"4"}},{"id":2016818,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2023-02-14T16:32:14.000Z","date":"2023-02-11","kind":"exercise","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":10075,"source":{"system":"sec-edgar","filing":"0001628280-23-003460","document":"wf-form4_167639231734061.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828023003460/wf-form4_167639231734061.xml","form_type":"4"}},{"id":2120137,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2022-11-10T20:29:01.000Z","date":"2022-11-08","kind":"exercise","acquired":false,"shares":1785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On November 8, 2021, the reporting person was granted 5,355 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On November 8, 2021, the reporting person was granted 5,355 restricted stock units, vesting in three equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":3570,"derivative":{"expiration_date":"2024-11-08","underlying":"Common Stock","underlying_shares":1785},"source":{"system":"sec-edgar","filing":"0001628280-22-029460","document":"wf-form4_166811212369585.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828022029460/wf-form4_166811212369585.xml","form_type":"4"}},{"id":2120136,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2022-11-10T20:29:01.000Z","date":"2022-11-08","kind":"tax_withholding","acquired":false,"shares":710,"price":14.52,"value":10309.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These shares were withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations. Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."}],"balance_after":6075,"source":{"system":"sec-edgar","filing":"0001628280-22-029460","document":"wf-form4_166811212369585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828022029460/wf-form4_166811212369585.xml","form_type":"4"}},{"id":2120135,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2022-11-10T20:29:01.000Z","date":"2022-11-08","kind":"exercise","acquired":true,"shares":1785,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":6785,"source":{"system":"sec-edgar","filing":"0001628280-22-029460","document":"wf-form4_166811212369585.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828022029460/wf-form4_166811212369585.xml","form_type":"4"}},{"id":2142334,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Stock Option","published_at":"2022-10-05T17:15:20.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":39055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":39055,"derivative":{"exercise_price":15.04,"expiration_date":"2027-10-02","underlying":"Common Stock","underlying_shares":39055},"source":{"system":"sec-edgar","filing":"0001628280-22-026031","document":"wf-form4_166499010544767.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828022026031/wf-form4_166499010544767.xml","form_type":"4"}},{"id":2142333,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2022-10-05T17:15:20.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":19947,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in three equal annual installments beginning October 3, 2023, the first anniversary of the grant date."}],"balance_after":19947,"derivative":{"underlying":"Common Stock","underlying_shares":19947},"source":{"system":"sec-edgar","filing":"0001628280-22-026031","document":"wf-form4_166499010544767.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000162828022026031/wf-form4_166499010544767.xml","form_type":"4"}},{"id":2170845,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2022-08-30T20:45:20.000Z","date":"2022-08-26","kind":"purchase","acquired":true,"shares":1000,"price":15.75,"value":15750.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001213900-22-052320","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000121390022052320/ownership.xml","form_type":"4"}},{"id":2355240,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2022-03-03T21:45:43.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":2313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of OptimizeRx common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":2313,"derivative":{"underlying":"Common Stock","underlying_shares":2313},"source":{"system":"sec-edgar","filing":"0001213900-22-010597","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000121390022010597/ownership.xml","form_type":"4"}},{"id":2355239,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Stock Option","published_at":"2022-03-03T21:45:43.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":4690,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in three equal annual installments beginning March 1, 2023, the first anniversary of the grant date."}],"balance_after":4690,"derivative":{"exercise_price":43.24,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":4690},"source":{"system":"sec-edgar","filing":"0001213900-22-010597","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000121390022010597/ownership.xml","form_type":"4"}},{"id":2394751,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2022-02-15T21:45:27.000Z","date":"2022-02-11","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On February 11, 2021, the reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date"}],"balance_after":16000,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001213900-22-007910","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000121390022007910/ownership.xml","form_type":"4"}},{"id":2394750,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Common Stock","published_at":"2022-02-15T21:45:27.000Z","date":"2022-02-11","kind":"exercise","acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":4000,"source":{"system":"sec-edgar","filing":"0001213900-22-007910","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000121390022007910/ownership.xml","form_type":"4"}},{"id":2518043,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Restricted Stock Units","published_at":"2021-11-10T21:45:32.000Z","date":"2021-11-08","kind":"grant","acquired":false,"shares":5355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the OptimizeRx's common stock. The restricted stock units will vest 1/3 at the end of each anniversary from issuance. Any restricted stock unit that has not been earned and vested as of the third anniversary of the grant date will be forfeited. Vesting of the restricted stock units shall accelerate upon a qualifying termination."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the OptimizeRx's common stock. The restricted stock units will vest 1/3 at the end of each anniversary from issuance. Any restricted stock unit that has not been earned and vested as of the third anniversary of the grant date will be forfeited. Vesting of the restricted stock units shall accelerate upon a qualifying termination."}],"balance_after":25335,"derivative":{"expiration_date":"2024-11-08","underlying":"Common Stock","underlying_shares":5335},"source":{"system":"sec-edgar","filing":"0001213900-21-058166","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000121390021058166/ownership.xml","form_type":"4"}},{"id":2518042,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Stock Option","published_at":"2021-11-10T21:45:32.000Z","date":"2021-11-08","kind":"grant","acquired":false,"shares":10958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Stock Option will vest 1/3 at the end of each anniversary from issuance."}],"balance_after":10958,"derivative":{"exercise_price":93.37,"exercise_date":"2022-11-08","expiration_date":"2026-11-08","underlying":"Common Stock","underlying_shares":10958},"source":{"system":"sec-edgar","filing":"0001213900-21-058166","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000121390021058166/ownership.xml","form_type":"4"}},{"id":2863857,"issuer":{"id":213,"kind":"organization","name":"OptimizeRx Corp","symbol":"OPRX"},"owners":[{"id":20391,"kind":"person","name":"Odence-Ford Marion","position":1,"cik":"0001845002","reported_name":"Odence-Ford Marion","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel and CCO"}}],"security":"Unvested Restricted Stock Award","published_at":"2021-02-12T21:46:05.000Z","date":"2021-02-11","kind":"grant","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/5 at the end of each anniversary from issuance."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/5 at the end of each anniversary from issuance."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Reporting Person acquired these shares pursuant to a Restricted Stock Award. The award vests 1/5 at the end of each anniversary from issuance."}],"balance_after":20000,"derivative":{"exercise_date":"2022-02-11","expiration_date":"2026-02-11","underlying":"Common","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001213900-21-009036","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1845002/000121390021009036/ownership.xml","form_type":"4"}}]}